论文部分内容阅读
水痘是一种常见的急性、高传染性的疾病 ,可感染儿童、成人。 1974年日本首先研制成功Oka株水痘减毒活疫苗 ,1984年世界卫生组织批准水痘减毒活疫苗用于婴幼儿预防接种 ,许多国家陆续开展了水痘疫苗预防接种 ,不仅能取得良好的防病效果 ,而且可较大地减轻疾病负担。对儿童、青少年、成人、育龄期妇女和免疫功能抑制患者分别进行的经济学评价表明 ,接种水痘疫苗具有较好的成本效益结果。
Chickenpox is a common acute, highly contagious disease that can affect children and adults. In 1974, Japan first developed a live attenuated varicella vaccine Oka strain, in 1984 the World Health Organization approved live attenuated varicella vaccine for infants and young children vaccination, many countries have launched a vaccination against varicella, not only can achieve good disease control effect , But also greatly reduce the burden of disease. Economic assessments of children, adolescents, adults, women of childbearing age and immunosuppressive patients, respectively, show that vaccination with chickenpox has cost-effective results.